James G Wood

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. doi request reprint Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia
    James G Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, Level 2, Children s Hospital at Westmead, NSW 2145, Sydney, Australia
    Vaccine 27:313-8. 2009
  2. pmc Optimal dosing and dynamic distribution of vaccines in an influenza pandemic
    James Wood
    School of Public Health and Community Medicine, University of New South Wales, New South Wales, Australia
    Am J Epidemiol 169:1517-24. 2009
  3. doi request reprint Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia
    Zhanhai Gao
    School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 31:691-7. 2013
  4. pmc Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies
    Anthony T Newall
    University of New South Wales, Sydney, New South Wales, Australia
    Emerg Infect Dis 16:224-30. 2010
  5. doi request reprint Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability
    Anthony T Newall
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, NSW, 2052, Australia
    Pharmacoeconomics 31:693-702. 2013
  6. pmc Effects of internal border control on spread of pandemic influenza
    James G Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Sydney, New South Wales, Australia
    Emerg Infect Dis 13:1038-45. 2007
  7. doi request reprint Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of children
    Anthony T Newall
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 30:5776-81. 2012
  8. doi request reprint The potential cost-effectiveness of infant pneumococcal vaccines in Australia
    Anthony T Newall
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 29:8077-85. 2011
  9. pmc Contact tracing of tuberculosis: a systematic review of transmission modelling studies
    Matt Begun
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia
    PLoS ONE 8:e72470. 2013
  10. doi request reprint Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination
    Ning Song
    School of Public Health and Community Medicine, University of New South Wales, High Street, Kensington, Sydney, NSW 2052, Australia
    Vaccine 30:4073-8. 2012

Collaborators

Detail Information

Publications11

  1. doi request reprint Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia
    James G Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, Level 2, Children s Hospital at Westmead, NSW 2145, Sydney, Australia
    Vaccine 27:313-8. 2009
    ..One-dose MMR coverage of 96% or greater maintained elimination more effectively than modelled changes in scheduling, suggesting that maximising one-dose MMR coverage should be the highest priority...
  2. pmc Optimal dosing and dynamic distribution of vaccines in an influenza pandemic
    James Wood
    School of Public Health and Community Medicine, University of New South Wales, New South Wales, Australia
    Am J Epidemiol 169:1517-24. 2009
    ..However, if prevalence at vaccination is above 1%, effectiveness is much reduced, emphasizing the need for other control measures...
  3. doi request reprint Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia
    Zhanhai Gao
    School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 31:691-7. 2013
    ..28 to 0.78 by 2060. The 99% reduction in both rubella and CRS incidence and low effective reproductive number (R≤0.28) we documented after 2010 are consistent with Australia having achieved rubella elimination...
  4. pmc Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies
    Anthony T Newall
    University of New South Wales, Sydney, New South Wales, Australia
    Emerg Infect Dis 16:224-30. 2010
    ..At a willingness to pay of >A$24,000 per life-year saved, more than half the simulations showed that a prepandemic vaccination program combined with antiviral treatment was cost-effective in Australia...
  5. doi request reprint Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability
    Anthony T Newall
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, NSW, 2052, Australia
    Pharmacoeconomics 31:693-702. 2013
    ..The universal vaccination of children for influenza has recently been recommended in the UK and is being considered in other developed countries...
  6. pmc Effects of internal border control on spread of pandemic influenza
    James G Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Sydney, New South Wales, Australia
    Emerg Infect Dis 13:1038-45. 2007
    ..Internal border control may have a role in protecting domestic centers early in a pandemic, when importations are sparse. Our results may be useful for policymakers...
  7. doi request reprint Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of children
    Anthony T Newall
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 30:5776-81. 2012
    ..The methodological approach used to estimate influenza hospitalisations was also highly influential. Our study highlights the role that key modelling assumptions play when estimating the impact of vaccination against influenza...
  8. doi request reprint The potential cost-effectiveness of infant pneumococcal vaccines in Australia
    Anthony T Newall
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 29:8077-85. 2011
    ..The high proportion of current invasive disease caused by serotype 19A (as included in PCV-13) may be a decisive factor in determining vaccine policy in Australia...
  9. pmc Contact tracing of tuberculosis: a systematic review of transmission modelling studies
    Matt Begun
    School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia
    PLoS ONE 8:e72470. 2013
    ..Our findings highlight the potential for collaborative work between clinicians, epidemiologists and modellers to gather data required to enhance model development and validation and hence better inform future public health policy. ..
  10. doi request reprint Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination
    Ning Song
    School of Public Health and Community Medicine, University of New South Wales, High Street, Kensington, Sydney, NSW 2052, Australia
    Vaccine 30:4073-8. 2012
    ..Further reductions in incidence of CRS will require continued attention to vaccine coverage in overseas-born women, as well as the maintenance of current high coverage level of two-dose MMR vaccination...
  11. ncbi request reprint Cost-effectiveness analyses of human papillomavirus vaccination
    Anthony T Newall
    School of Public Health, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
    Lancet Infect Dis 7:289-96. 2007
    ..Further refinements to model design and epidemiological variables of (type-specific) HPV disease progression, and expansions on the options for vaccine use, are required for policy making...